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Prevalence and determinants of type 2 diabetes 
among lean African migrants and non-migrants: 
the RODAM study
Background Exposure to adverse conditions 
earlier in life-course can predispose to type 2 
diabetes in adulthood, irrespective of body mass 
index (BMI). However, the burden of type 2 di-
abetes in lean Africans is not well understood 
despite higher exposure to adverse early life 
conditions. Mirroring ongoing epidemiological 
transition, we assessed the burden and determi-
nants of type 2 diabetes in a homogenous group 
of lean Ghanaians residing in rural and urban 
Ghana, and as migrants in Europe.
Methods Baseline data from 2179 RODAM 
study participants with BMI<25kg/m2 (25-70 
years) were analyzed. Prevalence and determi-
nants of type 2 diabetes were estimated using 
logistic regression analysis. Adjustments were 
made for socio-demographic and lifestyle fac-
tors, use of anti-diabetic medication and optimal 
blood glucose control.
Results Prevalence of type 2 diabetes in ru-
ral, urban and migrant lean participants were 
3.5%, 8.9% and 7.5% respectively, representing 
55.4%, 35.6%, 13.2% of all participants with 
type 2 diabetes. Compared with lean rural par-
ticipants, the odds of type 2 diabetes were higher 
in lean urban participants (adjusted OR = 8.81, 
95% CI = 6.56-11.06), followed by migrants 
(5.27, 95% CI = 3.51-6.91). Irrespective of site, 
determinants of type 2 diabetes in lean partici-
pants include; presence of hypertension, physi-
cal inactivity, hypercholesterolemia and age (>45 
years).
Conclusions Our study shows a high preva-
lence of type 2 diabetes among lean African 
populations in different geographical settings. 
Future studies are needed in-order to examine 
how contextual differences are related to the 
pathophysiology of type 2 diabetes in lean in-
dividuals.
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The online version of this article contains supplementary material.
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It is well established that there is an emerging burden of type 2 diabetes and other cardio-metabolic dis-
eases in sub-Saharan Africa (SSA) [1,2]. Although obesity is a well-known risk factor for type 2 diabetes, 
populations from low and middle income countries (LMIC) are at increased risk of type 2 diabetes at 
lower levels of body mass index (BMI) [3]. This is in contrast to high-income countries (HIC) where only 
about 20% of individuals with type 2 diabetes have normal BMI [4,5]. For many SSA countries, where 
health care resources are severely constrained, occurrence of type 2 diabetes in underweight/normal in-
dividuals poses major public health challenges such as increased mortality as a result of obesity paradox, 
increased rates of colorectal cancer and inapplicability of universally recommended lifestyle interventions 
such as body weight reduction [6-8].
Type 2 diabetes in underweight/normal weight individuals has been attributed to exposure to adverse 
conditions earlier in life-course [9,10]. This is in addition to the classical risk factors for type 2 diabetes 
such as alcohol consumption, smoking and physical inactivity [7]. Despite the higher rates of maternal 
undernutrition, pre-natal injurious agents and early childhood undernutrition in SSA, the burden of type 
2 diabetes in underweight/normal weight Africans is still not well understood [11]. Additionally, there is 
need for diabetes control strategies to be applied according to specific rural, urban and migrant contexts 
due to rapid urbanization, migration and epidemiological transition [1]. However, little is also known 
about the determinants of type 2 diabetes in each of the rural, urban and migrant SSA contexts.
Current reports show that the major pathophysiology of type 2 diabetes in underweight/normal weight 
individuals is rapid beta cell failure as opposed to insulin resistance [8]. Therefore, investigating the bur-
den of type 2 diabetes in non-obese populations and respective determinants in each geographical con-
text will expand knowledge well beyond the connection between lifestyle factors, insulin resistance and 
type 2 diabetes. Novel aspects of the relationship between developmental origins of disease and patho-
physiology of type 2 diabetes can be unraveled, thereby presenting opportunities for groundbreaking ap-
proaches to preventing and managing the disease [12].
In order to accentuate the environmental contributions to development of type 2 diabetes among under-
weight/normal weight individuals and mitigate the effects of dissimilar genetic background, it is imper-
ative that a homogenous group of people is studied [13]. We, therefore, used data from a homogenous 
group of Ghanaians who participated in the Research on Obesity and Diabetes among African Migrants 
(RODAM) study in order to 1) assess the prevalence of type 2 diabetes in underweight/normal weight 
SSA populations in rural, urban and migrant contexts. 2) assess the proportion of types 2 diabetes cases 
comprised of underweight/normal weight populations in each SSA context. 3) assess the determinants 
of type 2 diabetes in underweight/normal weight populations in each SSA context. 4) assess the relative 
contribution of beta cell failure and insulin resistance to type 2 diabetes in underweight/normal weight 
SSA populations.
METHODS
Study setting and population
The multicentre RODAM study was initiated in 2012 with the aim of understanding the complex inter-
play between the environment and genetics in the development of obesity and diabetes among African 
migrants. The full details of the study have been published elsewhere [13]. In brief, 5898 Ghanaian men 
and women aged 25-70 years were recruited in Europe and in Ghana. In Europe, participants were re-
cruited from the cities of Amsterdam (Netherlands), Berlin (Germany) and London (United Kingdom). 
In Ghana, recruitment of participants in the urban area was conducted in two purposively chosen cities 
(Kumasi and Obuasi), while recruitment in the rural area was conducted in 15 villages in the Ashanti re-
gion. A standardised approach for questionnaires, anthropometric measurements and venepuncture sam-
ples was used across all study sites. The response rates were 67% in Amsterdam, 68% in Berlin, 75% in 
London, 76% in rural Ghana and 74% in urban Ghana. Since our study was designed to study interna-
tional migration, we categorized Ghanaians living in Europe as migrants while Ghanaians living in Gha-
na were considered as non-migrants.
Ethical approval and consent to participate
Ethical approval was obtained from ethics committees of involved institutions in Ghana, Netherlands, 
Germany and UK before the start of data collection. All participants gave written informed consent.
Type 2 diabetes among lean African migrants and non-migrants
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Underweight/normal weight individuals with Type 2 diabetes
Presence of type 2 diabetes was defined using the World Health Organization (WHO) diagnostic crite-
ria (fasting blood glucose, ≥7.0 mmol/L, or current use of medication prescribed to treat type 2 diabetes 
or a previous self-reported diagnosis of type 2 diabetes a health professional. We used the current WHO 
definition of low/normal weight (ie, BMI<25kg/m2) to identify underweight/normal weight individuals 
in our study [14].
Measurements
The following measurements were obtained through a structured questionnaire; age, sex, educational at-
tainment, history of type 2 diabetes, use of medication for type 2 diabetes, use of dietary treatment for type 
2 diabetes, physical activity levels, alcohol consumption, smoking and length of stay in Europe. Education 
was categorised as follows; (1) none or elementary, 2) lower secondary, 3) higher secondary, and 4) ter-
tiary. Levels of physical activity were calculated using the Global Physical Activity Questionnaire (GPAQ) 
version 2, and categorised into a low, moderate or high levels based on the GPAQ criteria [15]. Alcohol 
consumption was categorised into no consumption, or any consumption. Smoking was categorised into 
current smokers, past smokers or non-smoker. Body weight was measured in light clothing and without 
shoes with SECA 877 scales to the nearest 0.1 kg. Participants height was measured without shoes with 
a portable stadiometer (SECA 217) to the nearest 0.1 cm. BMI was calculated as weight (kg) divided by 
height squared (m2). Central obesity was defined as waist-to-hip ratio (WHR) of ≥0.95 for men and ≥0.85 
for women. Blood pressure (BP) was measured three times using appropriate cuffs in a sitting position 
after at least 5 minutes of rest (mmHg). The mean of the last two measurements was used in the analysis.
All biochemical analyses were performed in Berlin with an ABX Pentra 400 chemistry analyser (ABX Pen-
tra; Horiba ABX, Montpellier, France). Concentration of total cholesterol, low density lipoprotein (LD-
L)-cholesterol, high density lipoprotein (HDL)-cholesterol and triglycerides was assessed using colori-
metric test kits (mmol/L). Insulin concentrations were assessed using the Mercodia ELISA kit in pmol/L. 
Fasting plasma glucose concentration was measured using an enzymatic method (hexokinase) in mmol/L. 
Glycated hemoglobin (HbA1c) was measured in % and mmol/mol (HPLC). Hypercholesterolemia was 
defined as total cholesterol ≥200mg/dL, low density lipoprotein (LDL) -cholesterol ≥160mg/dL, high den-
sity lipoprotein (HDL)-cholesterol ≤40mg/dL, triglycerides ≥150mg/dL or medication with lipid lower-
ing drugs. Impaired fasting glucose (IFG) was defined as a fasting glucose between 5.6 and 6.9 mmol/L, 
according to American Diabetes Association. Insulin sensitivity and beta cell function were assessed us-
ing Homeostatic Model Assessment (HOMA): HOMA-derived insulin resistance index (HOMA-IR) and 
HOMA-derived beta cell function (HOMA-B) [16]. HbA1c <7% (53 mmol/mol) was used to show op-
timal blood glucose control in individuals with type 2 diabetes for the preceding two to three months.
Data analysis
Data analyses were performed using Stata 14 (Stata Corp LP, Texas 77845, USA). Summary statistics 
were presented as proportions for categorical variables and as means (with standard deviations) for nor-
mally distributed continuous variables or medians (with IQR-interquartile range) for skewed continuous 
variables. The differences of baseline characteristics in rural, urban and migrant participants were test-
ed by Analysis of Variance (ANOVA) for normally distributed continuous variables, Kruskal-Wallis test 
for skewed continuous variables and χ2 tests for categorical variables. Prevalence of type 2 diabetes was 
calculated and standardised for age with a direct method. Logistic regression models were used to calcu-
late odds ratios with corresponding 95% Confidence Intervals (CI) for type 2 diabetes in underweight/
normal weight participants by location of current residency (rural Ghana as the reference category), ad-
justing for socio-demographic factors. In multivariable models, adjustments were made for alcohol con-
sumption, smoking, physical activity, blood pressure, receiving treatment for type 2 diabetes (weight-loss 
diet, oral medications and insulin use), level of blood glucose control (HbA1c <7% /53mmol/mol) and 
length of stay for migrants. For adjustment variables, missing values represented <5% of the data in ev-
ery variable. In addition, univariate and multivariate logistic regression models were used to assess the 
associations between type 2 diabetes in underweight/normal weight individuals and its determinants by 
location of current residency.
In a sub-set of underweight/normal weight participants with IFG, we assessed the association of HOMA-IR 
and HOMA-B with IFG using logistic regression models. This sub-analysis was carried out in order to 
identify whether beta cell failure or insulin resistance was more associated with the development of type 
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2 diabetes in underweight/normal weight individuals. In these models; first, we calculated the inverse of 
HOMA-B (ie, 1/HOMA-B). Second, we converted both HOMA-IR and inverse HOMA-B into standard-
ized z scores in order to achieve comparability of the variables. Third, we calculated the odds of IFG by 
1SD increase in HOMA-IR and inverse HOMA-B adjusting for age, sex and location of residency. Lastly, 
we calculated the attributable risk for inverse HOMA-B and HOMA-IR relative to IFG.
RESULTS
Baseline characteristics
A total of 2179 (37.1%) of all RODAM study participants were underweight/normal weight, of which, 
853(39.1%) were rural residents, 583(26.8%) were urban residents and 743(34.1%) were migrants (Fig-
ure S1 in Online Supplementary Document). In these underweight/normal weight participants, the 
majority of migrants were male (61.2%), while the majority of rural and urban participants were females 
(53.6% and 55.6%, respectively). About half (50.1%) of underweight/normal weight participants were 
older than 45 years. Median age was highest in rural residents, who were also the least educated. Medi-
an length of stay in Europe among migrants was 13 years (IQR, 5.1-22.2). Rural participants were more 
likely to be former smokers, and had the highest levels of physical activity and triglycerides. Urban par-
ticipants had the highest level of total cholesterol, LDL-cholesterol, hypercholesterolemia and WHR. Mi-
grants had the highest level of mean BMI, HDL-cholesterol, blood pressure, and were more likely than 
rural and urban participants to drink alcohol and smoke (Table 1).
Type 2 diabetes in underweight/normal weight individuals
Median fasting blood glucose and insulin levels were highest in underweight/normal weight urban res-
idents. The crude prevalence of type 2 diabetes in underweight/normal weight participants was 3.6% 
among rural residents, 8.8% among urban residents and 6.2% among migrants, with an overall preva-
lence of 5.9%. About 47% of all underweight/normal weight individuals with type 2 diabetes were on 
treatment (diet and medication). The most common mode of treatment was oral-antidiabetic agents in all 
three groups. Use of insulin for type 2 diabetes treatment was more common in migrants. The majority 
(63%) of underweight/normal weight migrants on type 2 diabetes treatment had achieved optimal blood 
glucose control in the preceding 2-3 months (Table 1).
When standardized for age, prevalence of type 2 di-
abetes in underweight/normal weight individuals 
was 3.5%, 8.9% and 7.5% in rural residents, ur-
ban residents, and migrants, respectively (Figure 1). 
The proportions of type 2 diabetes in underweight/
normal weight individuals relative to all type 2 di-
abetes cases were 55.4% for rural residents, 35.6% 
for urban residents and 13.2% for migrants (Figure 
2). Compared to rural residents, the odds of type 
2 diabetes in underweight/normal weight individu-
als were higher in both urban residents (OR = 8.81, 
95% CI = 6.56-11.06) and migrants (OR = 5.27, 95% 
CI = 3.51-6.91) compared to rural residents when 
adjusted for other factors (Figure 3).
In the subset of 217 underweight/normal weight in-
dividuals with IFG (compared to those with nor-
mal blood glucose), the odds for IFG were higher 
per 1SD increase in inverse HOMA-B (AOR = 16.07, 
95% CI = 10.16-25.41) compared to HOMA-IR 
(AOR = 9.83, 95% CI = 6.91-13.99), with corre-
spondingly higher attributable risk (AR)% for in-
verse HOMA-B (AR% 43.57, 95% CI = 35.30-51.84) 
than for HOMA-IR (AR% 32.86, 95% CI = 27.02-
38.70) (Table S1 in Online Supplementary Doc-
ument).
Figure 1. Crude and age -standardized prevalence of type 2 diabetes in 
underweight/normal weight urban residents, rural residents and mi-
grants. Age-standardized prevalence of type 2 diabetes in underweight/ 
normal weight participants includes confidence intervals as follows; ru-
ral residents 3.52% (95% CI = 2.29-4.45), urban residents 8.93% (95% 
CI = 6.59-11.27), migrants 7.49% (95% CI = 4.89-6.85). T2D – type 2 
diabetes mellitus.
Type 2 diabetes among lean African migrants and non-migrants
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Determinants of type 2 diabetes in underweight/normal weight participants
In underweight/normal weight rural residents, presence of hypertension (AOR = 2.24, 95% CI = 1.82-6.09) 
and high levels of physical activity (AOR = 0.22, 95% CI = 0.06-0.78) were independent determinants of 
type 2 diabetes. In underweight/normal weight urban residents, middle age (45-65 years) (AOR = 4.89, 
95% CI = 1.66-14.40), hypercholesterolemia (AOR = 10.53, 95% CI = 3.85-28.79) and presence of hyper-
tension (AOR = 3.76, 95% CI = 1.62-8.72) were independent determinants of type 2 diabetes. In under-
Table 1. Baseline characteristics of participants in migrant, urban and rural residents*
ToTal (n = 2179) MigranTs (n = 743) Urban residenTs (n = 583) rUral residenTs (n = 853)
Demographics
Women, n (%) 1069 (49.1) 288 (38.8) 324 (55.6) 457 (53.6)†
Mean age, years 45.07 (13.89) 41.17 (12.74) 44.59 (12.59) 48.77 (14.69)†
Age group, n (%):
25-44 1070 (49.11) 429 (57.74) 290 (49.74) 351 (41.15)†
45-65 898 (41.21) 287 (38.63) 257 (44.08) 354 (41.50)
>65 211 (9.68) 27 (3.63) 36 (6.17) 148 (17.35)
Education, n (%):
Elementary 825 (40.52) 115 (17.04) 239 (42.45) 471 (59.02)†
Lower secondary 700 (34.38) 157 (34.67) 227 (40.32) 239 (29.95)
Higher secondary 309 (15.18) 104 (26.81) 66 (11.72) 62 (7.77)
Tertiary 202 (9.92) 100 (21.48) 31 (5.51) 26 (3.26)
Lifestyle risk factors
BMI, n (%):
<18 206 (9.45) 14 (1.88) 33 (5.66) 159 (18.64)†
18.0-24.9 1973 (90.55) 729 (98.12) 550 (94.34) 694 (81.36)
Median BMI, kg/m2 22.01 (20.24-23.68) 23.20 (21.69-24.16) 22.08 (20.64-23.73) 20.58 (18.97-22.34)†
Raised waist-to-hip ratio (WHR), n (%) 1074 (49.36) 279 (37.65) 330 (56.70) 465 (54.51)
Mean total cholesterol, mmol/L 4.67 (1.12) 4.85 (1.08) 4.94 (1.08) 4.35 (1.10)c
Mean HDL cholesterol, mmol/L 1.32 (0.41) 1.48 (0.39) 1.29 (0.33) 1.20 (0.38)†
Mean LDL cholesterol, mmol/L 2.91 (0.94) 2.99 (0.94) 3.18 (0.92) 2.67 (0.91)†
Mean Triglycerides, mmol/L 0.85 (0.65-1.14) 0.71 (0.56-0.94) 0.89 (0.69-1.19) 0.95 (0.73-1.23)†
Hypercholesterolemia, n (%) 83 (5.94) 13 (2.24) 41 (11.06) 29 (6.79)
Mean Systolic BP, mmHg 125.52 (19.91) 128.40 (17.34) 124.46 (21.45) 123.78 (20.65)†
Mean Diastolic BP, mmHg 78.22 (12.04) 80.77 (11.63) 77.60 (12.59) 76.41 (11.63)†
Hypertension, n (%) 609 (27.95) 257 (34.59) 142 (24.36) 210 (24.62)†
High level physical activity, n (%) 1023 (54.18) 254 (47.65) 288 (51.43) 481 (60.50)†
Smoking, n (%):
Current 87(4.28) 54(8.00) 10(1.77) 23(2.89)‡
Past 156(7.67) 49(7.26) 39(6.91) 68(8.54)†
Any alcohol consumption, n (%) 853 (39.15) 320 (43.07) 169 (28.99) 364 (42.67)†
Median length of stay, years 13.12 (5.11-22.21) 13.12 (5.11-22.21)
Diabetes related
Median fasting blood glucose, mmol/L 4.95 (4.60-5.32) 4.91 (4.57-5.33) 5.04 (4.71-5.40) 4.89 (4.55-5.27)†
Median Insulin levels,(pmol/L) 3.9 (2.5-6.1) 4.3 (2.8-6.3) 4.4 (2.4-6.8) 3.4 (2.2-5.3)†
Impaired Fasting Glucose, n (%) 217 (10.58) 80 (11.48) 57 (10.71) 80 (9.73)†
Mean HOMA-IR 1.19 (1.53) 1.24 (1.92) 1.35 (1.48) 1.01 (1.09)†
Mean Inverse HOMA-B 0.03 (0.05) 0.02 (0.03) 0.03 (0.08) 0.02 (0.04)†
Diabetics, n (%) 128 (5.87) 46 (6.19) 51 (8.75) 31 (3.63)†
On diabetes treatment, n (%) 60 (46.87) 27 (58.69) 25 (49.02) 8 (25.81)‡
On diabetic diet, n (%) 37 (61.67) 11 (40.74) 18 (72.0) 8 (100.0)
On oral anti-diabetic drugs, n (%) 54 (90.0) 21 (77.78) 25 (100.0) 8 (100.0)
On Insulin treatment, n (%) 3 (5.0) 4 (14.81) 3 (12.0) 0
HbA1c levels <7% (53 mmol/mol), n (%) 28 (46.67) 17 (62.96) 7 (28.00) 4 (50.00)
IQR – interquartile range; SD – standard deviation, BMI – body mass index, HDL – high density lipoprotein, LDL – low density lipoprotein, BP – blood 
pressure, HOMA – homeostatic model assessment, HOMA-IR – HOMA-derived insulin resistance index (HOMA-IR), and HOMA-derived beta cell 
function (HOMA-B), HbA1c – glycated hemoglobin
*Data are n (%), median (interquartile range, IQR), or mean (standard deviation, SD).
†P for difference in baseline characteristics between migrants, urban and rural participants <0.001.
‡P for difference in baseline characteristics between migrants, urban and rural participants >0.05.
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weight/normal weight migrants, presence of hypertension (AOR = 4.45, 95% CI = 1.38-14.32) and older 
age (>65 years) (AOR = 9.84, 95% CI = 2.22-23.71) were independently associated with type 2 diabetes 
(Table 2).
DISCUSSION
Key findings
Our study shows that type 2 diabetes in underweight/normal weight individuals is very common in dif-
ferent Ghanaian contexts. The highest prevalence of type 2 diabetes in all underweight/normal weight 
individuals is in urban residents. However, underweight/normal weight individuals with type 2 diabetes 
Figure 3. Odds of type 2 diabetes in underweight/normal weight urban residents and migrants, com-
pared to rural – Ghanaians. Data are odds ratio (95% Confidence Interval). Model 1 – adjusted for 
age, sex and education. Model 2 – Model 1 with further adjustment for alcohol consumption, smok-
ing, physical activity, hypercholesterolemia, hypertension and length of stay in the migrants. Model 3 
– Model 2 with further adjustment for blood glucose control (HbA1c <7% (53 mmol/mol)) and dia-
betes treatment (diet, oral medication and insulin use).
Figure 2. Proportion of type 2 diabetes in underweight / normal 
weight participants within the RODAM study. T2D – type 2 diabe-
tes mellitus.
Type 2 diabetes among lean African migrants and non-migrants
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make up the highest proportion of all type 2 diabetes cases in rural residents. Determinants of type 2 dia-
betes in underweight/normal weight individuals include; presence of hypertension and physical inactiv-
ity among rural residents, middle age (45-65 years), hypercholesterolemia and presence of hypertension 
among urban residents, older age (>65 years) and presence of hypertension among migrants.
Interpretation of key findings
In our study, we found that the overall prevalence of type 2 diabetes in underweight/normal weight indi-
viduals was 5.9%, which is lower than the prevalence of type 2 diabetes in the overweight (10.3%) and 
obese (12.2%) reported from the same RODAM study [13]. This finding was expected since obesity is a 
well-known risk factor for type 2 diabetes, with the prevalence of type 2 diabetes increasing with increas-
ing BMI [17]. In addition, our study found that the overall proportion of type 2 diabetes in underweight/
normal weight individuals with respect to all type 2 diabetes cases was 24%, a figure which is higher 
than those reported in European or USA cohorts ie, 7.5% in the German DiaRegis (Diabetes treatment 
patterns and goal achievement in primary diabetes care) cohort, 8.4% in the German DIVE (Diabetes 
Versorgungs-Evaluation) cohort, 12% in the NHS (Nurses’ Health Study) and 16.5% in HPFS (Health 
Professionals Follow-Up Study) cohort [18-20]. This finding is expected considering that risk factors for 
type 2 diabetes in underweight/normal weight individuals such as maternal undernutrition, low birth 
weight, childhood undernutrition are more common in SSA populations, hence predisposing SSA pop-
ulations (including international migrants living in Europe) to type 2 diabetes as opposed to their Euro-
pean host populations [11,21].
Our study is the first to mirror the epidemiological transition in Africa and report the differences in type 
2 diabetes in underweight/normal weight individuals by location of residency. The highest odds of type 
2 diabetes in underweight/normal weight individuals were higher in urban residents, followed by mi-
grants. This finding was unexpected considering that fetal exposure to maternal undernutrition, pre-na-
tal injurious agents and early childhood undernutrition are more common in the rural areas and could 
greatly increase the risk of type 2 diabetes in the rural group [16]. However, it should be noted that type 
2 diabetes in underweight/normal weight rural residents accounted for the majority (55%) of all type 2 
diabetes cases, with only 13% of all type 2 diabetes cases in migrants consisting of underweight/ normal 
weight individuals. In our study, differences in the measured risk factors did not explain the observed 
higher odds of type 2 diabetes in urban residents compared to migrants. Previous studies have shown 
that metabolically unhealthy normal weight (MUNW) individuals are at risk of type 2 diabetes than met-
abolically healthy normal weight (MHNW) individuals [7]. MUNW encompasses glucose elevation in the 
presence of impaired insulin secretion, hypercholesterolemia, low leg fat mass, visceral obesity and fatty 
liver [7]. It is likely that the unmeasured MUNW contributes to the higher odds of type 2 diabetes in ur-
ban residents compared to migrants, but this need to be explored with further studies.
Variation of type 2 diabetes determinants by geographical context in underweight/normal weight individ-
uals was anticipated. First, previous studies have reported that underweight/normal weight individuals at 
risk of type 2 diabetes present with a lipodystrophy like syndrome [7]. Evidence from our study showed 
that underweight/normal weight urban residents had a greater proportion of hypercholesterolemia com-
pared to other groups, which would increase the risk of type 2 diabetes in this group. However, hyper-
cholesterolemia results from a complex interplay of diet, physical activity and genetics. The higher levels 
of hypercholesterolemia in the urban residents could also be a direct result of physical inactivity and un-
healthy diets as observed in our study [22].
Second, there is substantial overlap between diabetes and hypertension, reflecting a significant overlap in 
their etiology and disease mechanisms, including the sympathetic nervous system, renin–angiotensin–al-
dosterone system (RAAS), oxidative stress, adipokines, and peroxisome proliferator-activated receptors 
(PPARs) [23]. Hypertension has been reported in about 50% to 80% of individuals with type 2 diabetes 
[24]. It has also been reported that hypertensive subjects are 2.5 times more likely to develop type 2 dia-
betes [25]. In our study, hypertension was a determinant of type 2 diabetes in underweight/normal weight 
individuals in all three study groups. However, the odds of type 2 diabetes from hypertension were high-
est in underweight/normal weight individual migrants who also had the highest levels of hypertension at 
baseline compared to other groups.
It is worth noting that, individuals diagnosed with type 2 diabetes at older ages (60 years in men and 70 
years in women in SSA) tend to be less overweight due to loss of muscle mass, impairment of pancreat-
Type 2 diabetes among lean African migrants and non-migrants
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ic function, and increased intra-abdominal fat [26,27]. Therefore, it was not surprising that old age was 
associated with type 2 diabetes in underweight/normal weight individuals, especially in migrants. Nev-
ertheless, the effects of age on type 2 diabetes were not apparent in underweight/normal weight rural res-
idents, even though this group had the highest number of old participants. Thus, it is unclear why old 
age is not associated with type 2 diabetes in the underweight/normal weight rural group.
It is well established that physical exercise is protective against type 2 diabetes [28]. In our study, under-
weight/normal weight individuals with type 2 diabetes were 50% less likely to have higher levels of phys-
ical activity compared to those without type 2 diabetes. High levels of physical activity were seen in rural 
residents, which may contribute to the lowest risk of type 2 diabetes in this group.
Alcohol consumption and smoking were not associated with type 2 diabetes in underweight/normal 
weight individuals. In contrast, previous studies have shown that alcohol consumption and smoking 
predispose individuals to type 2 diabetes in underweight/normal weight individuals, especially in the 
western context [7]. The lack of a significant association between alcohol consumption and smoking 
with type 2 diabetes in underweight/normal weight individuals in the current study may be due to 
the low prevalence of smoking and alcohol consumption among our study population. For example, 
the prevalence of smoking and high alcohol consumption were around 44.6% and 12% in the Ger-
man DIVE study respectively, [18] whereas only 4.3% our respondents were smokers and 6.2% had 
any consumption of alcohol. It could be that our study did not have sufficient power to detect such 
associations.
The pathogenic mechanism of type 2 diabetes in underweight/normal weight individuals populations 
has been reported as predominantly beta cell failure, as opposed to insulin resistance, which is the ma-
jor pathophysiology of type 2 diabetes in overweight/obese individuals [10]. In the subset of participants 
with IFG, we found higher odds of HOMA-B compared to HOMA-IR per increase in each SD. The attrib-
utable risk for HOMA-B was also higher than that of HOMA-IR. This finding shows that pancreatic beta 
cell failure also makes a relatively larger contribution to the pathophysiology of type 2 diabetes in under-
weight/normal weight SSA populations as opposed to insulin resistance [29].
Strengths and limitations
The strength of our study is that it assesses a homogenous population of migrant and non-migrant Gha-
naians living in different settings in Africa and Europe using standardised methods, which mitigates the 
effects the effects of studying different SSA populations with dissimilar genetic background. Several lim-
itations of this study should be considered. First, our data are cross-sectional and rely on self-reported 
measures for socio-demographic and lifestyle risk factors hence we cannot preclude the possibility of re-
call bias. Second, some participants were underweight/normal weight due to weight loss effects of type 
2 diabetes medication (biguanides, GLP-1 receptor agonists, SLGT2 inhibitors), or even poor control of 
blood glucose [30-32].We adequately controlled for these effects in the logistic regression models, there-
by increasing the accuracy of our results. Third, we did not have data on early life adverse factors such 
as maternal undernutrition, low birthweight, prematurity, childhood malnutrition, epigenetics and mea-
sures of MUNW. Lastly, our numbers were too few to stratify the analysis by sex, hence we could not re-
ported sex differences in our study.
CONCLUSIONS
Our findings are highly relevant to SSA countries with a predominantly rural population and undergo-
ing rapid urbanization, yet have limited resources to tackle type 2 diabetes. Underweight/normal weight 
individuals are neglected in the prevention of type 2 diabetes since current recommendations for screen-
ing and lifestyle modifications are advised at a BMI greater than 25kg/m2. Worse still, rural areas have 
limited capacity to manage the detrimental effects of type 2 diabetes due to constrained resources. From 
our results, it is apparent that future studies should examine the pathophysiology of type 2 diabetes in 
underweight/normal weight individuals, including associations with maternal undernutrition, low birth 
weight, prematurity, childhood malnutrition, epigenetics, and MUNW concept. Furthermore, type 2 di-
abetes control efforts in SSA and African populations in Europe should be extended to underweight/nor-
mal weight individuals taking into account differences in rural, urban and migrant contexts.
Chilunga et al.
December 2019  •  Vol. 9 No. 2 •  020426 10 www.jogh.org •  doi: 10.7189/jogh.09.020426
V
IE
W
PO
IN
TS
PA
PE
RS
Acknowledgements: The authors are very grateful to the participants, research assistants, interviewers and 
other staff of the five research locations who have taken part in the study.
Funding: This work was supported by the European Commission under the Framework Programme [Grant 
Number: 278901]. FPC is supported by the Erasmus Mundus Joint Doctorate Program of the European Union 
through the Amsterdam Institute of Global Health and Development (AIGHD) [Grant Agreement 2015–1595].
Authors contributions: FPC, PH, and CA conceived and designed the study. FPC analyses the data. FPC, wrote 
the paper with the support of PH and CA. All authors FPC, PH, ARM, EB, KM, LS, JA, SB, ID, MBS, JS, EOD, 
KKG, MMAMM and CA participated in drafting the article or revising it critically for content.
Competing interests: The authors completed the Unified Competing Interest form at www.icmje.org/coi_dis-
closure.pdf (available upon request from the corresponding author), and declare no conflicts of interest.
Additional material
Online Supplementary Document
R
E
FE
R
E
N
C
E
S
  1  Atun R, Davies JI, Gale EA, Bärnighausen T, Beran D, Kengne AP, et al. Diabetes in sub-Saharan Africa: from clinical care 
to health policy. Lancet Diabetes Endocrinol. 2017;5:622-67. Medline:28688818 doi:10.1016/S2213-8587(17)30181-X
  2  Jamison DT, Alwan A, Mock CN, Nugent R, Watkins D, Adeyi O, et al. Universal health coverage and intersectoral action 
for health: key messages from Disease Control Priorities. Lancet. 2018;391:1108-20. Medline:29179954 doi:10.1016/
S0140-6736(17)32906-9
  3  Chiu M, Austin PC, Manuel DG, Shah BR, Tu JV. Deriving ethnic-specific BMI cutoff points for assessing diabetes risk. 
Diabetes Care. 2011;34:1741-8. Medline:21680722 doi:10.2337/dc10-2300
  4  Mokdad AH, Ford ES, Bowman BA, Dietz WH, Vinicor F, Bales VS, et al. Prevalence of obesity, diabetes, and obesity-re-
lated health risk factors, 2001. JAMA. 2003;289:76-9. Medline:12503980 doi:10.1001/jama.289.1.76
  5  Gujral UP, Mohan V, Pradeepa R, Deepa M, Anjana RM, Narayan K. Ethnic differences in the prevalence of diabetes in 
underweight and normal weight individuals: The CARRS and NHANES studies. Diabetes Res Clin Pract. 2018;146:34-
40. Medline:30244052 doi:10.1016/j.diabres.2018.09.011
  6  Kramer CK, Zinman B, Retnakaran R. Are metabolically healthy overweight and obesity benign conditions?: A system-
atic review and meta-analysis. Ann Intern Med. 2013;159:758-69. Medline:24297192 doi:10.7326/0003-4819-159-
11-201312030-00008
  7  Stefan N, Schick F, Häring H-U. Causes, characteristics, and consequences of metabolically unhealthy normal weight in 
humans. Cell Metab. 2017;26:292-300. Medline:28768170 doi:10.1016/j.cmet.2017.07.008
  8  Murphy N, Cross AJ, Abubakar M, Jenab M, Aleksandrova K, Boutron-Ruault M-C, et al. A nested case–control study of 
metabolically defined body size phenotypes and risk of colorectal cancer in the European Prospective Investigation into 
Cancer and Nutrition (EPIC). PLoS Med. 2016;13:e1001988. Medline:27046222 doi:10.1371/journal.pmed.1001988
  9  Feeley A, Musenge E, Pettifor JM, Norris SA. Changes in dietary habits and eating practices in adolescents living in urban 
South Africa: The birth to twenty cohort. Nutrition. 2012;28:e1-6. Medline:22465902 doi:10.1016/j.nut.2011.11.025
10  George AM, Jacob AG, Fogelfeld L. Lean diabetes mellitus: An emerging entity in the era of obesity. World J Diabetes. 
2015;6:613. Medline:25987958 doi:10.4239/wjd.v6.i4.613
11  Akombi BJ, Agho KE, Hall JJ, Wali N, Renzaho A, Merom D. Stunting, wasting and underweight in sub-Saharan Afri-
ca: a systematic review. Int J Environ Res Public Health. 2017;14:863. Medline:28788108 doi:10.3390/ijerph14080863
12  Davies JI, Macnab AJ, Byass P, Norris SA, Nyirenda M, Singhal A, et al. Developmental origins of health and disease in Afri-
ca—influencing early life. Lancet Glob Health. 2018;6:e244-5. Medline:29433658 doi:10.1016/S2214-109X(18)30036-6
13  Agyemang C, Beune E, Meeks K, Owusu-Dabo E, Agyei-Baffour P, Aikins AG, et al. Ad-G, et al. Rationale and cross-sec-
tional study design of the Research on Obesity and type 2 Diabetes among African Migrants: the RODAM study. BMJ 
Open. 2014;4:e004877. Medline:24657884 doi:10.1136/bmjopen-2014-004877
14  Organization WH. Global database on body mass index: an interactive surveillance tool for monitoring nutrition tran-
sition. Public Health Nutr. 2006;9:658-60.
15  Bull FC, Maslin TS, Armstrong T. Global physical activity questionnaire (GPAQ): nine country reliability and validity 
study. J Phys Act Health. 2009;6:790-804. Medline:20101923 doi:10.1123/jpah.6.6.790
16  Wallace TM, Levy JC, Matthews DR. Use and abuse of HOMA modeling. Diabetes Care. 2004;27:1487-95. Med-
line:15161807 doi:10.2337/diacare.27.6.1487
17  Riobó Serván P. Obesidad y diabetes. Nutr Hosp. 2013;28:138-43. Medline:24010754
18  Hartmann B, Lanzinger S, Bramlage P, Groß F, Danne T, Wagner S, et al. Lean diabetes in middle-aged adults: A joint 
analysis of the German DIVE and DPV registries. PLoS One. 2017;12:e0183235. Medline:28827839 doi:10.1371/jour-
nal.pone.0183235
19  Hartmann B, Bramlage P, Schneider S, Tschöpe D, Gitt A. Impact of body weight on antidiabetic treatment and predic-
tors of weight control under real-world conditions: a 2-year follow-up of DiaRegis cohort. Acta Diabetol. 2015;52:1093-
101. Medline:26239142 doi:10.1007/s00592-015-0794-0
Type 2 diabetes among lean African migrants and non-migrants
www.jogh.org •  doi: 10.7189/jogh.09.020426 11 December 2019  •  Vol. 9 No. 2 •  020426
V
IE
W
PO
IN
TS
PA
PE
RS
R
E
FE
R
E
N
C
E
S
20  Tobias DK, Pan A, Jackson CL, O’reilly EJ, Ding EL, Willett WC, et al. Body-mass index and mortality among adults with 
incident type 2 diabetes. N Engl J Med. 2014;370:233-44. Medline:24428469 doi:10.1056/NEJMoa1304501
21  Hanson MA, Gluckman P. Early developmental conditioning of later health and disease: physiology or pathophysiology? 
Physiol Rev. 2014;94:1027-76. Medline:25287859 doi:10.1152/physrev.00029.2013
22  Galbete C, Nicolaou M, Meeks K, Klipstein-Grobusch K, Aikins AG, Ado J, et al. Aikins Ad-G, Addo J, et al. Dietary pat-
terns and type 2 diabetes among Ghanaian migrants in Europe and their compatriots in Ghana: the RODAM study. Nutr 
Diabetes. 2018;8:25. Medline:29695705 doi:10.1038/s41387-018-0029-x
23  Cheung BM, Li C. Diabetes and hypertension: is there a common metabolic pathway? Curr Atheroscler Rep. 2012;14:160-
6. Medline:22281657 doi:10.1007/s11883-012-0227-2
24  Landsberg L, Molitch M. Diabetes and hypertension: pathogenesis, prevention and treatment. Clin Exp Hypertens. 
2004;26:621-8. Medline:15702616 doi:10.1081/CEH-200031945
25  Gress TW, Nieto FJ, Shahar E, Wofford MR, Brancati FL. Hypertension and antihypertensive therapy as risk factors for 
type 2 diabetes mellitus. N Engl J Med. 2000;342:905-12. Medline:10738048 doi:10.1056/NEJM200003303421301
26  Price AJ, Crampin AC, Amberbir A, Kayuni-Chihana N, Musicha C, Tafatatha T, et al. Prevalence of obesity, hyperten-
sion, and diabetes, and cascade of care in sub-Saharan Africa: a cross-sectional, population-based study in rural and 
urban Malawi. Lancet Diabetes Endocrinol. 2018;6:208-22. Medline:29371076 doi:10.1016/S2213-8587(17)30432-1
27  Goodpaster BH, Krishnaswami S, Resnick H, Kelley DE, Haggerty C, Harris TB, et al. Association between regional ad-
ipose tissue distribution and both type 2 diabetes and impaired glucose tolerance in elderly men and women. Diabetes 
Care. 2003;26:372-9. Medline:12547865 doi:10.2337/diacare.26.2.372
28  Lumb A. Diabetes and exercise. Clin Med (Lond). 2014;14:673-6. Medline:25468857 doi:10.7861/clinmedicine.14-6-673
29  Meeks KA, Stronks K, Adeyemo A, Addo J, Bahendeka S, Beune E, et al. Peripheral insulin resistance rather than beta 
cell dysfunction accounts for geographical differences in impaired fasting blood glucose among sub-Saharan African in-
dividuals: findings from the RODAM study. Diabetologia. 2017;60:854-64. Medline:28144712 doi:10.1007/s00125-
017-4216-4
30  Lau DC, Teoh H. Impact of current and emerging glucose-lowering drugs on body weight in type 2 diabetes. Can J Di-
abetes. 2015;39:S148-54. Medline:26654858 doi:10.1016/j.jcjd.2015.09.090
31  Grams J, Garvey WT. Weight loss and the prevention and treatment of type 2 diabetes using lifestyle therapy, pharmaco-
therapy, and bariatric surgery: mechanisms of action. Curr Obes Rep. 2015;4:287-302. Medline:26627223 doi:10.1007/
s13679-015-0155-x
32  Kalyani RR, Tra Y, Egan J, Ferrucci L, Brancati F. Hyperglycemia is associated with relatively lower lean body mass in old-
er adults. J Nutr Health Aging. 2014;18:737-43. Medline:25286453 doi:10.1007/s12603-014-0538-9
